Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 1 chart position in 1 market.
By chart position
- 🇦🇪AE · Science#113500 to 3K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
150 to 900🎙 Daily cadence·80 episodes·Last published 4d ago - Monthly Reach
Unique listeners across all episodes (30 days)
500 to 3K🇦🇪100% - Active Followers
Loyal subscribers who consistently listen
200 to 1.2K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 14 epsHosts
Recent guests
Recent episodes
Colorectal Cancer — Fifth Annual National General Medical Oncology Summit
Jun 22, 2026
Unknown duration
Desmoid Tumors — Microlearning Activity 4 with Prof Bernd Kasper
Jun 22, 2026
Unknown duration
Gastroesophageal Cancers — Fifth Annual National General Medical Oncology Summit
Jun 19, 2026
Unknown duration
Pancreatic Cancer — Fifth Annual National General Medical Oncology Summit
Jun 15, 2026
Unknown duration
Desmoid Tumors — Microlearning Activity 3 with Prof Bernd Kasper
Jun 2, 2026
22m 50s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 6/22/26 | Colorectal Cancer — Fifth Annual National General Medical Oncology Summit | Featuring perspectives from Dr Kristen K Ciombor and Dr John Strickler, including the following topics:Introduction (0:00)Current and Future Role of Immune Checkpoint Inhibitors in the Management of Colorectal Cancer (CRC) — Dr Ciombor (3:58)Other Recent Advances in CRC Management — Dr Strickler (32:57)CME information and select publications | — | ||||||
| 6/22/26 | Desmoid Tumors — Microlearning Activity 4 with Prof Bernd Kasper | Featuring an interview with Prof Bernd Kasper, including the following topics:Case: A woman in her early 30s develops a progressing desmoid tumor in her abdomen during pregnancy(0:00)Case: A woman in her late 30s with a painful small desmoid tumor in her rectus abdominus undergoes cryoablation (8:04)Case: A woman in her late teens with recurrent desmoid tumors in her right thigh undergoes multiple resections (13:58)Case: A woman in her mid 70s has a desmoid tumor causing erosion in her scapular region (17:19)CME information and select publications | — | ||||||
| 6/19/26 | Gastroesophageal Cancers — Fifth Annual National General Medical Oncology Summit | Featuring perspectives from Dr Yelena Y Janjigian and Dr Samuel J Klempner, including the following topics:Introduction (0:00)Role of Anti-PD-1/PD-L1- and CLDN18.2-Directed Antibodies in the Management of Gastroesophageal Cancers — Dr Klempner (5:52)Management of HER2-Positive Gastroesophageal Cancers — Dr Janjigian (28:20)CME information and select publications | — | ||||||
| 6/15/26 | Pancreatic Cancer — Fifth Annual National General Medical Oncology Summit | Featuring perspectives from Dr Eileen M O’Reilly and Dr Philip A Philip, including the following topics: Introduction (0:00)Optimal Incorporation of Chemotherapy into the Management of Advanced Pancreatic Cancer — Dr Philip (7:27)Other Available and Emerging Novel Approaches for Pancreatic Cancer — Dr O’Reilly (28:05)CME information and select publications | — | ||||||
| 6/2/26 | Desmoid Tumors — Microlearning Activity 3 with Prof Bernd Kasper✨ | desmoid tumorstreatment strategies+1 | Prof Bernd Kasper | Mannheim Cancer Center | Mannheim, Germany | desmoid tumorstreatment+3 | — | 22m 50s | |
| 5/28/26 | Colorectal Cancer — Year in Review Series on Relevant New Datasets and Advances✨ | colorectal cancerclinical trials+3 | Dr Arvind DasariDr Anwaar Saeed | University of Texas MD Anderson Cancer CenterUPMC Hillman Cancer Center | HoustonPittsburgh | colorectal cancerclinical trials+3 | — | 58m 48s | |
| 5/20/26 | Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Microlearning Activity 4: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium✨ | immunotherapytargeted therapy+3 | Dr Jaffer A AjaniDr Rutika Mehta+1 | The University of Texas MD Anderson Cancer CenterWeill Cornell Medicine+2 | — | immunotherapytargeted therapy+5 | — | 8m 26s | |
| 5/3/26 | Localized Colorectal Cancer — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium✨ | localized colorectal cancerclinical findings+3 | Dr Stacey A CohenDr Jenny Seligmann+1 | Fred Hutchinson Cancer CenterUniversity of Leeds+1 | — | colorectal cancerASCO+5 | — | 18m 11s | |
| 4/24/26 | Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium✨ | immunotherapytargeted therapy+3 | Dr Jaffer AjaniDr Samuel Klempner+2 | The University of Texas MD Anderson Cancer CenterMassachusetts General Hospital+2 | — | immunotherapytargeted therapy+5 | — | 16m 54s | |
| 4/13/26 | Localized Colorectal Cancer — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium✨ | localized colorectal cancerclinical findings+3 | Dr Stacey A CohenDr Jenny Seligmann+1 | Fred Hutchinson Cancer CenterUniversity of Leeds+1 | — | colorectal cancerASCO+3 | — | 15m 06s | |
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 4/8/26 | HER2-Positive Gastrointestinal Cancers — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium✨ | HER2-positive gastrointestinal cancersclinical management+3 | Dr Haley EllisProf Eric Van Cutsem+1 | Harvard Medical SchoolUniversity Hospitals Leuven+2 | — | HER2-positivegastrointestinal cancers+3 | — | 15m 45s | |
| 4/7/26 | Desmoid Tumors — Microlearning Activity 2 with Dr Ravin Ratan✨ | desmoid tumorsclinical data+3 | Dr Ravin Ratan | The University of Texas MD Anderson Cancer CenterGastrointestinal Cancer Update | — | desmoid tumorsclinical data+4 | — | 28m 14s | |
| 4/3/26 | Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium✨ | immunotherapytargeted therapy+3 | Dr Jaffer AjaniDr Samuel Klempner+2 | The University of Texas MD Anderson Cancer CenterMassachusetts General Hospital+2 | — | immunotherapytargeted therapy+4 | — | 22m 10s | |
| 3/26/26 | Localized Colorectal Cancer — Microlearning Activity 1: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium✨ | localized colorectal cancerclinical findings+3 | Dr Stacey A CohenDr Jenny Seligmann+1 | Fred Hutchinson Cancer CenterUniversity of Leeds+1 | — | colorectal cancerASCO+3 | — | 17m 11s | |
| 3/24/26 | Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Microlearning Activity 1: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium✨ | immunotherapytargeted therapy+3 | Dr Jaffer AjaniDr Rutika Mehta+1 | The University of Texas MD Anderson Cancer CenterWeill Cornell Medicine/NewYork-Presbyterian Hospital+2 | — | immunotherapygastroesophageal cancer+3 | — | 24m 55s | |
| 3/19/26 | HER2-Positive Gastrointestinal Cancers — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium✨ | HER2-positive gastrointestinal cancersclinical management+3 | Dr Haley EllisProf Eric Van Cutsem+1 | Harvard Medical SchoolUniversity Hospitals Leuven+2 | — | HER2-positivegastrointestinal cancers+3 | — | 21m 38s | |
| 3/16/26 | Desmoid Tumors — Microlearning Activity 1 with Dr Ravin Ratan✨ | desmoid tumorsclinical data+3 | Dr Ravin Ratan | The University of Texas MD Anderson Cancer CenterGastrointestinal Cancer Update | — | desmoid tumorsclinical data+3 | — | 16m 43s | |
| 3/14/26 | HER2-Positive Gastrointestinal Cancers — Microlearning Activity 1: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium✨ | HER2-positive gastrointestinal cancersmanagement perspectives+3 | Dr Haley EllisProf Eric Van Cutsem+1 | Mayo ClinicMass General Brigham Cancer Institute+2 | — | HER2-positivegastrointestinal cancers+5 | — | 12m 53s | |
| 3/6/26 | Oncology Nursing Update: Colorectal Cancer — An Interview with Dr Christopher Lieu on Molecular Residual Disease Analysis | Dr Christopher Lieu from the University of Colorado Cancer Center in Aurora, Colorado, discusses circulating tumor DNA-based molecular residual disease assessment and its current role in the management of colorectal cancer.NCPD information and select publications here. | — | ||||||
| 2/26/26 | Colorectal Cancer — A Roundtable Discussion on the Use of Molecular Residual Disease Analysis | Dr Stacey A Cohen from the University of Washington in Seattle, Dr Arvind Dasari from The University of Texas MD Anderson Cancer Center in Houston, and Dr Christopher Lieu from the University of Colorado Cancer Center in Aurora discuss the role of molecular residual disease assessment using circulating tumor DNA-based tools in the management of colorectal cancer.CME information and select publications here. | — | ||||||
| 2/12/26 | Squamous Cell Carcinoma of the Anal Canal — An Interview with Dr Marwan Fakih | Dr Marwah Fakih from the City of Hope Comprehensive Cancer Center in Duarte, California, discusses current and potential therapeutic strategies for the treatment of squamous cell carcinoma of the anal canal.CME information and select publications here. | — | ||||||
| 2/6/26 | Localized Colorectal Cancer — Proceedings from a Session Held Adjunct to the 2026 ASCO Gastrointestinal Cancers Symposium | Dr Stacey A Cohen from Fred Hutchinson Cancer Center in Seattle, Washington, Dr Jenny Seligmann from the University of Leeds in the United Kingdom and Dr Christopher Lieu from the University of Colorado Cancer Center in Aurora review clinical findings from the 2026 ASCO Gastrointestinal Cancers Symposium relevant to the management of localized colorectal cancer.CME information and select publications here. | — | ||||||
| 2/2/26 | Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Proceedings from a Session Held Adjunct to the 2026 ASCO Gastrointestinal Cancers Symposium | Dr Jaffer Ajani from The University of Texas MD Anderson Cancer Center in Houston, Dr Rutika Mehta from Weill Cornell Medicine/NewYork-Presbyterian Hospital in New York, New York, Dr John Strickler from Duke University in Durham, North Carolina, and Dr Samuel Klempner from Massachusetts General Hospital in Boston review relevant data supporting immunotherapy for patients with gastroesophageal cancers and review recently presented clinical findings from the 2026 ASCO Gastrointestinal Cancers Symposium.CME information and select publications here. | — | ||||||
| 1/28/26 | HER2-Positive Gastrointestinal Cancers — Proceedings from a Session Held Adjunct to the 2026 ASCO Gastrointestinal Cancers Symposium | Dr Haley Ellis from Harvard Medical School in Boston, Massachusetts, Prof Eric Van Cutsem from University Hospitals Leuven in Belgium, Dr Zev Wainberg from UCLA School of Medicine in Los Angeles, California, and moderator Dr Lionel KankeuFonkoua from Mayo Clinic in Rochester, Minnesota, discuss recent data surrounding the management of HER2-positive GI cancers, alongside their perspectives on its clinical application and management.CME information and select publications here. | — | ||||||
| 1/12/26 | Colorectal Cancer — 5-Minute Journal Club Issue 2 with Dr Scott Kopetz: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays | Dr Scott Kopetz from The University of Texas MD Anderson Cancer Center in Houston discusses recent developments with circulating tumor DNA assays in the management of colorectal cancer. CME information and select publications here. | — | ||||||
Showing 25 of 89
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart Positions
1 placement across 1 market.
Chart Positions
1 placement across 1 market.